Vaccine Overview
Levocarnitine Injection USP
Levocarnitine injection is used to treat primary and secondary carnitine deficiency, especially in patients undergoing dialysis or with inborn metabolic disorders. It plays a crucial role in transporting fatty acids into mitochondria for energy production. Administered intravenously, it corrects metabolic imbalances and supports heart and muscle function. It is often used in critical care settings and in patients with chronic renal failure, improving energy metabolism and reducing symptoms such as fatigue and muscle weakness.
Drug Class: Pharma Products
Indication: Treatment and prevention of carnitine deficiency, especially in patients with end-stage renal disease or metabolic disorders.
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
During dialysis or when deficiency is diagnosed
Administration
Route: Intravenous (IV)
Site: Vein (central or peripheral)
Disease
Carnitine deficiency, often in renal or metabolic disorders
Manufacturer
Serum Intitute Of India
Age
- All age groups (including neonates)
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025